CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

AspirinWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (3)

Name (Synonyms) Correlation
drug749 Simvastatin Wiki 1.00
drug480 Losartan Wiki 0.38
drug616 Placebo Wiki 0.10

Correlated MeSH Terms (7)

Name (Synonyms) Correlation
D055371 Acute Lung Injury NIH 0.16
D012127 Respiratory Distress Syndrome, Newborn NIH 0.15
D012128 Respiratory Distress Syndrome, Adult NIH 0.13
D003141 Communicable Diseases NIH 0.12
D007239 Infection NIH 0.08
D045169 Severe Acute Respiratory Syndrome NIH 0.07
D018352 Coronavirus Infections NIH 0.06

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Aspirin, Losartan and Simvastatin in Hospitalised COVID-19 Patients: a Multinational Randomised Open-label Factorial Trial

The CRASH-19 trial is a multinational, open-label, factorial, randomised trial in adults hospitalised with suspected or confirmed acute COVID-19 infection.

NCT04343001 Covid-19 Drug: Aspirin Drug: Losartan Drug: Simvastatin

Primary Outcomes

Description: Cause of death will be described

Measure: Death

Time: up to 28 days of randomisation

Secondary Outcomes

Measure: Myocardial infarction

Time: up to 28 days of randomisation

Measure: Congestive cardiac failure

Time: up to 28 days of randomisation

Measure: Severe cardiac arrythmia

Time: up to 28 days of randomisation

Measure: Myocarditis

Time: up to 28 days of randomisation

Measure: Respiratory failure including ARDS

Time: up to 28 days of randomisation

Measure: Viral pneumonitis

Time: up to 28 days of randomisation

Measure: Acute renal failure

Time: up to 28 days of randomisation

Measure: Sepsis

Time: up to 28 days of randomisation

Measure: Stroke

Time: up to 28 days of randomisation

Measure: Gastrointestinal bleeding

Time: up to 28 days of randomisation

Measure: Receipt of non invasive or mechanical ventilation

Time: up to 28 days of randomisation

Measure: Ability to self care at hospital discharge

Time: up to 28 days of randomisation

No related HPO nodes (Using clinical trials)